“Ukatamanga weka utamangisa, tikatamanga awili, tifikapatali - When you run alone, you run fast. When you run together, you run far Zambian Proverb

UNZA-UCLMS

Research and Training Programme

Publications 2014

The neglected global burden of tuberculosis in pregnancy. Zumla A, Bates M, Mwaba P. The Lancet Global Health, Volume 2, Issue 12, Pages e675 - e676, December 2014


The host battles drug-resistant tuberculosis. Maeurer M, Zumla A. Sci Transl Med. 2014 Nov 19;


Neonatal Sepsis and Antibiotic Resistance in Developing Countries. Bates M, Kabwe M, Zumla A. Paed. Infect. Dis. J. Oct 2014 10.1097/INF.0000000000000388 PDF


Clinical features, microbiology and surgical outcomes of infective endocarditis: a 13-year study from a UK tertiary cardiothoracic referral centre. Marks DJ, Hyams C, Koo CY, Pavlou M, Robbins J, Koo CS, Rodger G, Huggett JF, Yap J, Macrae MB, Swanton RH, Zumla AI, Miller RF. QJM. 2014 Sep 15.


Pregnancy and Infection. Zumla A, Bates M, Maeurer M. N Engl J Med. 2014 Sep 11;371(11):1075-1077. PDF


Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, Pappas F, Phillips PP, Nunn AJ; REMoxTB Consortium. N Engl J Med. 2014 Oct 23;371(17):


Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Zumla A, Memish ZA, Maeurer M, Bates M, Mwaba P, Al-Tawfiq JA, Denning DW, Hayden FG, Hui DS. Lancet Infect Dis. 2014 Sep 1 PDF


Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread. McCloskey B, Dar O, Zumla A, Heymann DL. Lancet Infect Dis. 2014 Sep 1 PDF


Emerging viral respiratory tract infections-environmental risk factors and transmission. Gautret P, Gray GC, Charrel RN, Odezulu NG, Al-Tawfiq JA, Zumla A, Memish ZA. Lancet Infect Dis. 2014 Sep 1 PDF


Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections-needs, advances, and future prospects. Zumla A, Al-Tawfiq JA, Enne VI, Kidd M, Drosten C, Breuer J, Muller MA, Hui D, Maeurer M, Bates M, Mwaba P, Al-Hakeem R, Gray G, Gautret P, Al-Rabeeah AA, Memish ZA, Gant V. Lancet Infect Dis. 2014 Sep 1 PDF


Emerging respiratory tract infections. Zumla A, Hui DS, Al-Tawfiq JA, Gautret P, McCloskey B, Memish ZA. Lancet Infect Dis. 2014 Sep 1 PDF


Surveillance for emerging respiratory viruses. Al-Tawfiq JA, Zumla A, Gautret P, Gray GC, Hui DS, Al-Rabeeah AA, Memish ZA. Lancet Infect Dis. 2014 Sep 1 PDF


Transmission of MERS-coronavirus in household contacts. Drosten C, Meyer B, Müller MA, Corman VM, Al-Masri M, Hossain R, Madani H, Sieberg A, Bosch BJ, Lattwein E, Alhakeem RF, Assiri AM, Hajomar W, Albarrak AM, Al-Tawfiq JA, Zumla AI, Memish ZA. N Engl J Med. 2014 Aug 28;371(9):828-35.


Travel implications of emerging coronaviruses: SARS and MERS-CoV. Al-Tawfiq JA, Zumla A, Memish ZA. Travel Med Infect Dis. 2014 Jul 9.


Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers. Al-Tawfiq JA, Zumla A, Memish ZA. Curr Opin Infect Dis. 2014 Oct;27(5):411-7


Epidemiology and clinical management of Legionnaires' disease. Phin N, Parry-Ford F, Harrison T, Stagg HR, Zhang N, Kumar K, Lortholary O, Zumla A, Abubakar I. Lancet Infect Dis. 2014 Jun 23.


'Complex' but coping: experience of symptoms of tuberculosis and health care seeking behaviours - a qualitative interview study of urban risk groups, London, UK. Craig GM, Joly LM, Zumla A. BMC Public Health. 2014 Jun 18;14(1):618.


Euro 2012 European Football Championship Finals: planning for a health legacy. Smallwood CA, Arbuthnott KG, Banczak-Mysiak B, Borodina M, Coutinho AP, Payne-Hallström L, Lipska E, Lyashko V, Miklasz M, Miskiewicz P, Nitzan D, Pokanevych I, Posobkiewicz M, Rockenschaub G, Sadkowska-Todys M, Sinelnik S, Smiley D, Tomialoic R, Yurchenko V, Memish ZA, Heymann D, Endericks T, McCloskey B, Zumla A, Barbeschi M. Lancet. 2014 May 20.


Mass gatherings medicine: international cooperation and progress. Memish ZA, Zumla A, McCloskey B, Heymann D, Al Rabeeah AA, Barbeschi M, Horton R. Lancet. 2014 May 20.


Hajj: infectious disease surveillance and control. Memish ZA, Zumla A, Alhakeem RF, Assiri A, Turkestani A, Al Harby KD, Alyemni M, Dhafar K, Gautret P, Barbeschi M, McCloskey B, Heymann D, Al Rabeeah AA, Al-Tawfiq JA. Lancet. 2014 May 20.


Infection control and MERS-CoV in health-care workers. Zumla A, Hui DS. Lancet. 2014 May 20.


London 2012 Olympic and Paralympic Games: public health surveillance and epidemiology. McCloskey B, Endericks T, Catchpole M, Zambon M, McLauchlin J, Shetty N, Manuel R, Turbitt D, Smith G, Crook P, Severi E, Jones J, Ibbotson S, Marshall R, Smallwood CA, Isla N, Memish ZA, Al-Rabeeah AA, Barbeschi M, Heymann DL, Zumla A. Lancet. 2014 May 20


Respiratory Tract Samples, Viral Load and Genome Fraction Yield in patients with Middle East Respiratory Syndrome. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, Assiri A, Alhakeem RF, Albarrak A, Alsubaie S, Al-Rabeeah AA, Hajomar WH, Hussain R, Kheyami AM, Almutairi A, Azhar EI, Drosten C, Watson SJ, Kellam P, Cotten M, Zumla A. J Infect Dis. 2014 May 15.


Middle East Respiratory Syndrome Corona virus, MERS-CoV. Conclusions from the 2ndScientific Advisory Board Meeting of the WHO Collaborating Center for Mass Gathering Medicine, Riyadh. Memish ZA, Al-Tawfiq J, Drosten C, Assiri A, Alhakeem R, Albarrak A, Yezli S, Almasri M, Zumla A, Petersen E. Int J Infect Dis. 2014 May 10


Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, Ezechi O, Connolly C, Kapotwe V, Muwonge C, Massaga J, Sinkala E, Kohi W, Lyantumba L, Nyakoojo G, Luwaga H, Doulla B, Mzyece J, Kapata N, Vahedi M, Mwaba P, Egwaga S, Adatu F, Pym A, Joloba M, Rustomjee R, Zumla A, Onyebujoh P. Lancet Infect Dis. 2014 May 2.


Totally-drug resistant tuberculosis and adjunct therapies. Parida SK, Axelsson-Robertson R, Rao MV, Singh N, Master I, Lutckii A, Keshavjee S, Andersson J, Zumla A, Maeurer M. J Intern Med. 2014 May 8.


Triumphs, trials, and tribulations of the global response to MERS coronavirus. McNabb SJ, Shaikh AT, Nuzzo JB, Zumla AI, Heymann DL. Lancet Respir Med. 2014 May 1.


The Hajj pilgrimage and surveillance for Middle East Respiratory syndrome coronavirus in pilgrims from African countries. Zumla A, Mwaba P, Bates M, Al-Tawfiq JA, Maeurer M, Memish ZA. Trop Med Int Health. 2014 Apr 18.


Progress in tuberculosis vaccine development and host-directed therapies-a state of the art review. Kaufmann SH, Lange C, Rao M, Balaji KN, Lotze M, Schito M, Zumla AI, Maeurer M. Lancet Respir Med. 2014 Apr;2(4):301-320.


Totally-drug-resistant tuberculosis: hype versus hope. Maeurer M, Schito M, Zumla A. Lancet Respir Med. 2014 Apr;2(4):256-7.


Inflammation and tuberculosis: host-directed therapies. Zumla A, Rao M, Parida SK, Keshavjee S, Cassell G, Wallis R, Axelsson-Robertsson R, Doherty M, Andersson J, Maeurer M. J Intern Med. 2014 Apr 10.


Congenital cytomegalovirus infections in sub-Saharan Africa - a neglected and growing problem. Bates M, Tembo J, Zumla A. Trop Med Int Health. 2014 Apr 10. PDF


Community Case Clusters of Middle East Respiratory Syndrome Coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: A Descriptive Genomic study. Memish ZA, Cotten M, Watson SJ, Kellam P, Zumla A, Alhakeem RF, Assiri A, Rabeeah AA, Al-Tawfiq JA. Int J Infect Dis. 2014 Mar 31.


Rapid nucleic acid diagnostics for the detection of antimicrobial resistance in Gram-negative bacteria: is it time for a paradigm shift? Tuite N, Reddington K, Barry T, Zumla A, Enne V. J Antimicrob Chemother. 2014 Mar 27. 


New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects.

Zumla AI, Gillespie SH, Hoelscher M, Philips PP, Cole ST, Abubakar I, McHugh TD, Schito M, Maeurer M, Nunn AJ. Lancet Infect Dis. 2014 Apr;14(4):327-340.


Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines. Zumla AI, Schito M, Maeurer M. Lancet Infect Dis. 2014 Apr;14(4):267-9.


WHO's 2013 global report on tuberculosis: successes, threats, and opportunities. Zumla A, George A, Sharma V, Herbert N, Baroness Masham of Ilton. Lancet. 2013 Nov 30;382(9907):1765-7. PDF


Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance. Enne VI, Personne Y, Grgic L, Gant V, Zumla A. Curr Opin Pulm Med. 2014 Mar 7. 


Spread, circulation, and evolution of the middle East respiratory syndrome coronavirus. Cotten M, Watson SJ, Zumla AI, Makhdoom HQ, Palser AL, Ong SH, Al Rabeeah AA, Alhakeem RF, Assiri A, Al-Tawfiq JA, Albarrak A, Barry M, Shibl A, Alrabiah FA, Hajjar S, Balkhy HH, Flemban H, Rambaut A, Kellam P, Memish ZA. MBio. 2014 Feb 18;5(1). 


Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. Skrahin A, Ahmed RK, Ferrara G, Rane L, Poiret T, Isaikina Y, Skrahina A, Zumla A, Maeurer MJ. Lancet Respir Med. 2014 Feb;2(2):108-22. 


Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, Al-Rabeeah AA, Assiri A, Alhakeem RF, Alrabiah FA, Al Hajjar S, Albarrak A, Flemban H, Balkhy H, Barry M, Alhassan S, Alsubaie S, Zumla A. Clin Microbiol Infect. 2014 Jan 24. 


Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Friedrich SO, Rachow A, Saathoff E, Singh K, Mangu CD, Dawson R, Phillips PP, Venter A, Bateson A, Boehme CC, Heinrich N, Hunt RD, Boeree MJ, Zumla A, McHugh TD, Gillespie SH, Diacon AH, Hoelscher M; Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics (PanACEA). Lancet Respir Med. 2013 Aug;1(6):462-70.

Tuberculosis drug discovery in the post-post-genomic era. Lechartier B, Rybniker J, Zumla A, Cole ST. EMBO Mol Med. 2014 Jan 8.